Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Opitz

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Pancreas|September 26, 2025
Proteomic Characterization Reveals CYP2S1 as a Mediator of Drug Resistance in PDACVera Thiel, Wiebke M Nadler, Alexander Kerner, et al.
Journal of Viral Hepatitis|June 3, 2009
Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resourcesJ Wiegand, B Luz, A-K Mengelkamp, et al.
Oncoimmunology|March 28, 2017
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancerDyah L Dewi, Soumya R Mohapatra, Saioa Blanco Cabañes, et al.
Theranostics|October 14, 2021
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastomaVerena Panitz, Saša Končarević, Ahmed Sadik, et al.
Nature Metabolism|June 23, 2026
Host metabolism can produce many indoles and phenols independently of the microbiomeJenna E AbuSalim, Kellen Olszewski, Salma Youssef, et al.
Nature Communications|August 6, 2025
Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progressionLeo Carl Foerster, Oguzhan Kaya, Valentin Wüst, et al.
Nature Communications|October 17, 2025
Author Correction: Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progressionLeo Carl Foerster, Oguzhan Kaya, Valentin Wüst, et al.
Journal for Immunotherapy of Cancer|November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapyChristina Kober, Julian Roewe, Norbert Schmees, et al.
Nature Communications|October 27, 2019
Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecologyJana K Sonner, Melanie Keil, Maren Falk-Paulsen, et al.
Cell|August 21, 2020
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor ProgressionAhmed Sadik, Luis F Somarribas Patterson, Selcen Öztürk, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Pancreas|September 26, 2025
Proteomic Characterization Reveals CYP2S1 as a Mediator of Drug Resistance in PDACVera Thiel, Wiebke M Nadler, Alexander Kerner, et al.
Journal of Viral Hepatitis|June 3, 2009
Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resourcesJ Wiegand, B Luz, A-K Mengelkamp, et al.
Oncoimmunology|March 28, 2017
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancerDyah L Dewi, Soumya R Mohapatra, Saioa Blanco Cabañes, et al.
Theranostics|October 14, 2021
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastomaVerena Panitz, Saša Končarević, Ahmed Sadik, et al.
Nature Metabolism|June 23, 2026
Host metabolism can produce many indoles and phenols independently of the microbiomeJenna E AbuSalim, Kellen Olszewski, Salma Youssef, et al.
Nature Communications|August 6, 2025
Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progressionLeo Carl Foerster, Oguzhan Kaya, Valentin Wüst, et al.
Nature Communications|October 17, 2025
Author Correction: Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progressionLeo Carl Foerster, Oguzhan Kaya, Valentin Wüst, et al.
Journal for Immunotherapy of Cancer|November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapyChristina Kober, Julian Roewe, Norbert Schmees, et al.
Nature Communications|October 27, 2019
Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecologyJana K Sonner, Melanie Keil, Maren Falk-Paulsen, et al.
Cell|August 21, 2020
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor ProgressionAhmed Sadik, Luis F Somarribas Patterson, Selcen Öztürk, et al.
Pageof 16